financetom
Business
financetom
/
Business
/
Credo Technology Group Holding Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Shares Jump After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Credo Technology Group Holding Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Shares Jump After Hours
Jun 2, 2025 1:41 PM

04:24 PM EDT, 06/02/2025 (MT Newswires) -- Credo Technology Group Holding ( CRDO ) reported fiscal Q4 non-GAAP earnings late Monday of $0.35 per diluted share, up from $0.07 a year earlier.

Analysts polled by FactSet expected $0.27.

Revenue in the three months ended May 3 increased to $170 million from $60.8 million a year earlier.

Analysts surveyed by FactSet expected $159.6 million.

The company expects fiscal Q1 revenue of $185 million to $195 million. Analysts project $162.4 million.

Credo's shares jumped 14% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
Nov 13, 2025
(Reuters) -Metsera ( MTSR ) shareholders on Thursday approved Pfizer's ( PFE ) takeover offer worth up to $10 billion, as per preliminary count, allowing the U.S. pharmaceutical giant to gain a foothold in the lucrative obesity treatment market after a fierce bidding war with Wegovy-maker Novo Nordisk. The approval paves the way for Pfizer ( PFE ) to diversify...
US judge denies motions to disqualify officers, advisors involved in Citgo auction
US judge denies motions to disqualify officers, advisors involved in Citgo auction
Nov 13, 2025
HOUSTON, Nov 13 (Reuters) - A U.S. judge has denied motions filed by Venezuela and miner Gold Reserve ( GDRZF ) to disqualify him, a court officer and two advising firms overseeing an auction of shares in the parent of U.S. refiner Citgo Petroleum, according to a court filing on Thursday. ...
Why Canadian Solar's Stock Is Soaring Despite Posting Another Quarterly Loss
Why Canadian Solar's Stock Is Soaring Despite Posting Another Quarterly Loss
Nov 13, 2025
Canadian Solar Inc. ( CSIQ ) stock soared after delivering third-quarter 2025 net revenues of $1.487 billion, beating the $1.366 billion estimate, even as its adjusted loss of 58 cents per diluted share missed the expected 53-cent loss. Revenue slipped 12% sequentially and 1% year over year. Gross margin rose to 17.2%, above guidance and up from 16.4% a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved